Abdul Abdirahman
Principal
F-Prime
Principal investing in early-stage B2B software, fintech, and vertical SaaS.
Professional summary
Chong Xu is a Partner at F-Prime focused primarily on biopharmaceutical and medical technology investments. He works with Eight Roads Ventures Asia on portfolio companies and new investment opportunities in China, and has been involved in company formations including AlphaGen Tx, Pediatrix, Skyline Tx, K36 Tx, and RareStone Group. Before joining F-Prime in 2015, he worked at McKinsey, as a healthcare equity analyst at Massif Partners and Affirmed Healthcare, and as a developmental neurobiology researcher at Temasek Life Sciences Laboratory.
Selected portfolio companies the partner has backed
Career, education, and skills
12 more profiles